SG11202011861RA - Extract and dermatological composition comprising same, for treating sensitive skin - Google Patents

Extract and dermatological composition comprising same, for treating sensitive skin

Info

Publication number
SG11202011861RA
SG11202011861RA SG11202011861RA SG11202011861RA SG11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA SG 11202011861R A SG11202011861R A SG 11202011861RA
Authority
SG
Singapore
Prior art keywords
extract
same
sensitive skin
dermatological composition
treating sensitive
Prior art date
Application number
SG11202011861RA
Other languages
English (en)
Inventor
Nathalie Castex-Rizzi
Bertrand Chol
Fabrice Lestienne
Original Assignee
Fabre Pierre Dermo Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Pierre Dermo Cosmetique filed Critical Fabre Pierre Dermo Cosmetique
Publication of SG11202011861RA publication Critical patent/SG11202011861RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11202011861RA 2018-06-01 2019-05-31 Extract and dermatological composition comprising same, for treating sensitive skin SG11202011861RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1854794A FR3081705B1 (fr) 2018-06-01 2018-06-01 Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
PCT/EP2019/064211 WO2019229248A1 (fr) 2018-06-01 2019-05-31 Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles

Publications (1)

Publication Number Publication Date
SG11202011861RA true SG11202011861RA (en) 2020-12-30

Family

ID=63407394

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202011861RA SG11202011861RA (en) 2018-06-01 2019-05-31 Extract and dermatological composition comprising same, for treating sensitive skin

Country Status (14)

Country Link
US (1) US11857578B2 (fr)
EP (1) EP3801580B1 (fr)
JP (1) JP7357645B2 (fr)
KR (1) KR20210015871A (fr)
CN (1) CN112423769A (fr)
AR (1) AR117590A1 (fr)
AU (1) AU2019276356A1 (fr)
BR (1) BR112020023771A2 (fr)
CA (1) CA3100594A1 (fr)
ES (1) ES2964122T3 (fr)
FR (1) FR3081705B1 (fr)
MX (1) MX2020012882A (fr)
SG (1) SG11202011861RA (fr)
WO (1) WO2019229248A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102621138B1 (ko) 2023-05-12 2024-01-05 주식회사 포레스트에비뉴 시트프리 거품형 마스크팩 조성물 및 이를 활용한 거품형 마스크팩

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918884B1 (fr) 2007-07-17 2010-01-15 Oreal Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2969658B1 (fr) * 2010-12-22 2014-10-17 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation therapeutique
FR2969657B1 (fr) 2010-12-22 2014-02-07 Fabre Pierre Dermo Cosmetique Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie
CA3042879A1 (fr) * 2016-11-10 2018-05-17 Allergan, Inc. Methodes permettant d'attenuer un prurit independant de l'histamine a l'aide de neurotoxines
FR3065009B1 (fr) * 2017-04-06 2020-11-27 Fabre Pierre Dermo Cosmetique Secretome bacterien pour son utilisation dans le traitement des lesions cutanees

Also Published As

Publication number Publication date
MX2020012882A (es) 2021-02-18
ES2964122T3 (es) 2024-04-04
AU2019276356A1 (en) 2020-12-17
AR117590A1 (es) 2021-08-18
EP3801580A1 (fr) 2021-04-14
JP7357645B2 (ja) 2023-10-06
WO2019229248A1 (fr) 2019-12-05
BR112020023771A2 (pt) 2021-03-23
EP3801580B1 (fr) 2023-08-30
KR20210015871A (ko) 2021-02-10
CA3100594A1 (fr) 2019-12-05
US20210353690A1 (en) 2021-11-18
EP3801580C0 (fr) 2023-08-30
CN112423769A (zh) 2021-02-26
FR3081705B1 (fr) 2020-12-04
US11857578B2 (en) 2024-01-02
JP2021526373A (ja) 2021-10-07
FR3081705A1 (fr) 2019-12-06

Similar Documents

Publication Publication Date Title
PT3244819T (pt) Dispositivo para o tratamento cosmético de manchas cutâneas castanhas por criogenia
EP3657980A4 (fr) Masques à base de levure pour améliorer la santé de la peau, des cheveux et du cuir chevelu
ZA201902275B (en) Topical dressing composition for the treatment of damaged skin tissue
IL282871A (en) Systems and methods for skin treatment
EP3476382A4 (fr) Agent de traitement de poudre pour cosmétique, poudre pour cosmétique, et cosmétique formulé en utilisant ladite poudre
EP3554310A4 (fr) Composition de traitement de la peau emballée et procédé
EP3902605A4 (fr) Méthodes et compositions pour traiter des troubles cutanés et capillaires
EP3653196A4 (fr) Masque cosmétique à appliquer sur la peau et procédé d'application
EP3849591A4 (fr) Méthodes et compositions pour traiter des maladies de la peau
EP3677274A4 (fr) Composition pour prévenir et traiter une maladie de la peau comprenant une substance se liant spécifiquement à un peptide dérivé de la vimentine
MX2017013819A (es) Metodos para la reduccion de grasa.
GB2588994B (en) Combar for skin and hair treatment
EP3461486A4 (fr) Composition pharmaceutique pour la prévention ou le traitement de la démence et l'amélioration de la fonction cognitive, comprenant un extrait de salicorne
EP3466406A4 (fr) Composition cosmétique anti-taches, système de compositions et procédé pour le traitement cosmétique de la peau
SG11202011861RA (en) Extract and dermatological composition comprising same, for treating sensitive skin
HK1256935A1 (zh) 使用疫苗治療癌症或皮膚病變的方法和組合物
EP3677267A4 (fr) Composition pharmaceutique pour le traitement ou la prévention de tumeurs, méthode et utilisation de celle-ci
EP3501493A4 (fr) Composition cosmétique anti-rides, utilisation de cette composition, méthode de traitement anti-rides et dispositif d'application
EP3342417A4 (fr) Composition pour l'amincissement du corps et le soin de la peau et procédé de préparation associé
GB201611406D0 (en) Skin care composition and method thereof
IL281501A (en) Preparations and methods for the treatment of cellulite
PT3515399T (pt) Composição cosmética ou farmacêutica para tonificação da pele, fixação da pele e redução de rugas
SG11202002451TA (en) Composition for treating fine dust-caused skin cell damage, comprising prunus mume flower extract
EP3501494A4 (fr) Composition cosmétique anti-rides, utilisation de cette composition et méthode de traitement anti-rides
EP3501492A4 (fr) Composition cosmétique anti-rides, utilisation de cette composition, méthode de traitement anti-rides et dispositif d'application